rs17018468
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_052953.4(LRRC3B):c.-161+22849A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 152,146 control chromosomes in the GnomAD database, including 1,415 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1415 hom., cov: 31)
Consequence
LRRC3B
NM_052953.4 intron
NM_052953.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.286
Publications
1 publications found
Genes affected
LRRC3B (HGNC:28105): (leucine rich repeat containing 3B) The protein encoded by this gene is a tumor suppressor, with lowered expression levels found in gastric, renal, colorectal, lung, and breast cancer tissues. The promoter of this gene is frequently hypermethylated in these cancer tissues, although the hypermethylation does not appear to be the cause of the reduced expression of this gene. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.271 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.124 AC: 18884AN: 152028Hom.: 1413 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
18884
AN:
152028
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.124 AC: 18898AN: 152146Hom.: 1415 Cov.: 31 AF XY: 0.126 AC XY: 9384AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
18898
AN:
152146
Hom.:
Cov.:
31
AF XY:
AC XY:
9384
AN XY:
74374
show subpopulations
African (AFR)
AF:
AC:
5966
AN:
41504
American (AMR)
AF:
AC:
1611
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
696
AN:
3470
East Asian (EAS)
AF:
AC:
1458
AN:
5152
South Asian (SAS)
AF:
AC:
1150
AN:
4826
European-Finnish (FIN)
AF:
AC:
760
AN:
10600
Middle Eastern (MID)
AF:
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6706
AN:
67988
Other (OTH)
AF:
AC:
293
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
830
1661
2491
3322
4152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
744
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.